“…Tem p erature is Controlled *Seiji Takaoka, tRobert D. Bart, +Robert Pearlstein, §Ann Brinkhous, and §David S. Warner During MCAO and the first 24 h of reperfusion, rats (n = 10) were administered either vehicle or the glycine an tagonist 5-nitro-6,7-dichloro-2,3-quinoxalinedione (ACEA 1021) i,v, as a bolus infusion of 5 mg/kg followed by 3,5 mg/kg/h (Low-Dose) or 10 mg/kg followed by 7 mg/kg/ A theoretical pharmacologic approach to amelio ration of ischemic brain damage is antagonism of the glycine recognition site of the N-methyl-o-aspartate (NMDA) receptor complex, Glycine and glutamate are required to co-activate the NMDA receptor be fore the associated ionophore becomes permeable to calcium (Dalkara et al, 1992;Forsythe et al, 1988;Lester et al, 1993). Glycine has also been demon-h (High-Dose) for 24 h, Cortical temperature was con trolled at 38,0 ± 0,1 DC during MCAO and the first 6 h of reperfusion, A 7-day recovery interval was allowed, Mean total infarct volume was reduced by -40% in both high and low-dose groups (p < 0.01), The preponderance of infarct reduction occurred in the cortex (p < 0,01), Neuro logic function correlated with the size of cerebral infarct (p = 0,001), Neurologic grade was similarly improved by treatment with either dose (p = 0,01), These results demon strate that neuroprotection achieved by antagonism of the glycine recognition site persists when brain temperature is controlled, indicating a potent mechanism of action other than attenuating a hyperthermic response to ischemia, Key Words: NMDA-Glycine antagonists-Neuroprotec tion-Brain temperature-Ischemia, strated to potentiate glutamate toxicity in cultured neurons (Johnson and Ascher, 1987).…”